Fingerprint
Dive into the research topics where Kira Gritsman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 7 Finished
-
PI3 Kinase Inactivation in Myelodysplastic Syndrome
Gritsman, K. (PI)
9/1/22 → 5/31/23
Project: Research project
-
PI3 Kinase Inactivation in Myelodysplastic Syndrome
Gritsman, K. (PI)
National Institute of Diabetes and Digestive and Kidney Diseases
9/17/21 → 8/31/22
Project: Research project
-
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
Gritsman, K. (PI)
4/1/16 → 3/31/21
Project: Research project
-
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
Gritsman, K. (PI) & Gritsman, K. (CoPI)
4/1/16 → 3/31/21
Project: Research project
-
The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia
Gritsman, K. (PI)
9/15/10 → 8/31/15
Project: Research project
-
A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia
Chakraborty, S., Morganti, C., Zaldana, K., Rivera Pena, B., Zhang, H., Verma, D., Gitego, N., Ma, F., Aluri, S., Pradhan, K., Gordon-Mitchell, S., Mantzaris, I., Goldfinger, M., Feldman, E., Gritsman, K., Shi, Y., Hubner, S., Qiu, Y. H., Brown, B. D. & Khasawneh, A. & 13 others, , Apr 2026, In: Leukemia. 40, 4, p. 717-729 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study
Amaeshi, L., Laufer, L., Fedorov, K., Sisto, A., Levitz, D., Mathew, R., Wright, K., Cooper, D., Goldfinger, M., Mantzaris, I., Sica, R. A., Gritsman, K., Konopleva, M., Gupta, R., Kornblum, N., Zhang, C., Kim, M., Verma, A., Rapkin, B. & Shastri, A. & 1 others, , 2026, In: JMIR Cancer. 12, e68101.Research output: Contribution to journal › Article › peer-review
Open Access -
Adding the FcRn antagonist efgartigimod for the prevention of IgG-mediated complications in the peri-transplant period
Cooper, D. L., Verceles, J. A., Kheradmand, T., Paroder, M., Lombardo, A., de Castro, A., Browne, R., Konopleva, M., Moavero, B., Goldfinger, M., Mantzaris, I., Kornblum, N., Sica, R. A., Shastri, A., Shapiro, L. C., Peeke, S. Z., Gupta, R., Gritsman, K., Feldman, E. J. & Verma, A., Oct 2025, In: Transfusion. 65, 10, p. 1978-1981 4 p.Research output: Contribution to journal › Article › peer-review
-
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
Gor, R., Shivakumar, J., Surana, P., Wei, J., Murakhovskaya, I., Goldfinger, M., Kornblum, N., Shapiro, L., Shastri, A., Gupta, R., Levitz, D., Konopleva, M., Feldman, E., Gritsman, K., Sica, R. A., Mantzaris, I., Verma, A., Cooper, D., Janakiram, M. & Shah, N., Dec 2025, In: Blood cancer journal. 15, 1, 140.Research output: Contribution to journal › Article › peer-review
Open Access -
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases
Shah, N., Suchanek, M., Thakkar, A., Patel, R. J., Rahman, S., Acuna-Villaorduna, A., Shah, U., Adrianzen Herrera, D., Slasky, S., Gritsman, K., Goldfinger, M., Shastri, A., Mantzaris, I., Kornblum, N., Bachier-Rodriguez, L., Feldman, E., Cooper, D., Mcneill, K. A., Wang, Y. & Shi, Y. & 4 others, , Jul 1 2025, In: JCO Precision Oncology. 9, e2300526.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations